Health Ministry warns diabetics over faulty insulin pens

The Czech Health Ministry on Friday warned against three batches of NovoMix 30 Flexpen insulin pens, produced by the firm Novo Nordisk. They were found to contain inconsistent amounts of the active ingredient and are being withdrawn from the market. Some 2,500 Czech diabetes patients are at risk of using the pens; the ministry said they can receive new insulin pens free of charge. The warning came from the EU’s medicines agency and applies to 12 countries of the bloc.